Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Adam L. Green is active.

Publication


Featured researches published by Adam L. Green.


JAMA Pediatrics | 2015

Ethnic, Racial, and Socioeconomic Disparities in Retinoblastoma

Bao Truong; Adam L. Green; Paola Friedrich; Karina Braga Ribeiro; Carlos Rodriguez-Galindo

IMPORTANCE Most children with retinoblastoma in the United States are diagnosed as having a large intraocular tumor burden that requires intensive ocular-salvage treatment or enucleation. OBJECTIVE To investigate the effect of socioeconomic status, race, and ethnicity on the extent of disease and the outcomes of retinoblastoma. DESIGN, SETTING, AND PARTICIPANTS A population-based review of 18 Surveillance, Epidemiology, and End Results (SEER) registries. From January 1, 2000, through December 31, 2010, 830 cases of retinoblastoma were recorded for children aged 0 to 9 years. Data were collected and analyzed from January 1, 2000, through December 31, 2010, with the last follow-up on December 31, 2010. EXPOSURES County-based socioeconomic variables analyzed included poverty level, educational attainment, language isolation, crowding, unemployment, and percentage of immigrants. MAIN OUTCOMES AND MEASURES Extent of disease, ocular outcome, and childrens survival. RESULTS Of the 830 individuals included, Hispanic children had a higher percentage of extraocular disease (86 of 261 [33.0%] vs. 102 of 510 non-Hispanic children [20.0%]; odds ratio [OR], 1.97 [95% CI, 1.38-2.79]). The percentage of extraocular cases was also higher in counties with the following low socioeconomic status indicators: higher vs. lower poverty status (115 of 413 [27.8%] vs. 73 of 358 [20.4%]; OR, 1.51; 95% CI, 1.06-2.14); lower vs. higher educational attainment (115 of 400 [28.7%] vs. 73 of 371 [19.7%]; OR, 1.65; 95% CI, 1.16-2.34); higher vs. lower levels of crowding (124 of 398 [31.2%] vs. 64 of 373 [17.2%]; OR, 2.18; 95% CI, 1.53-3.13); higher vs. lower unemployment (119 of 411 [28.9%] vs. 69 of 360 [19.2%]; OR, 1.72; 95% CI, 1.21-2.45); higher vs. lower language isolation (117 of 388 [30.2%] vs. 71 of 383 [18.5%]; OR, 1.89; 95% CI, 1.34-2.70); and higher vs. lower percentage of immigrants (109 of 386 [28.2%] vs. 79 of 385 [20.5%]; OR, 1.52; 95% CI, 1.08-2.16). Higher rates of enucleation were associated with low educational attainment (265 of 401 [66.1%] vs 309 of 421 [73.4%]; OR, 1.42; 95% CI, 1.04-1.93), a higher level of crowding (316 of 416 [76.0%] vs. 258 of 406 [63.5%]; OR, 1.81; 95% CI, 1.32-2.48), and Hispanic origin (202 of 271 [74.5%]; OR, 1.41; 95% CI, 1.01-1.98). Relative survival at 5 years was lower among black compared with non-Hispanic white children (92.7% vs. 99.2%; P < .001). CONCLUSIONS AND RELEVANCE Significant disparities exist in the care and outcomes of children with retinoblastoma. A low socioeconomic status negatively affects disease extent and ocular outcomes, presumably by limiting access to primary and cancer-directed care. Hispanic children in particular have more advanced disease and higher rates of enucleation.


American Journal of Perinatology Reports | 2013

BRAF V600E-Positive Multisite Langerhans Cell Histiocytosis in a Preterm Neonate

Sara V. Bates; Ashwini Lakshmanan; Adam L. Green; Jefferson Terry; Gayane Badalian-Very; Barrett J. Rollins; Patricia Fleck; Muhammad Aslam; Barbara A. Degar

Hemorrhagic pustules with a “blueberry muffin” appearance accompanied by respiratory failure in a neonate present a challenging differential diagnosis that includes infections and neoplasms. We present a case of multiorgan, multisite Langerhans cell histiocytosis (LCH), positive for the oncogenic BRAF V600E mutation, in a preterm neonate. Infants with LCH pose a diagnostic challenge due to their heterogeneous presentations. This case is unusual in that the newborn presented with severe multiorgan involvement. Due to the rare incidence, wide spectrum of clinical manifestations, and high mortality rate, clinicians must maintain a high index of suspicion for LCH.


Journal of Pediatric Oncology Nursing | 2014

Cerebellar mutism after posterior fossa tumor resection: case discussion and recommendations for psychoeducational intervention.

Sarah G. Ross; Lisa Northman; Marybeth Morris; Adam L. Green; Nicole J. Ullrich

Cerebellar mutism (also known as posterior fossa syndrome) is a relatively common complication of posterior fossa surgery for primary brain tumors in children. Many children with cerebellar mutism experience long-term adverse neurological, cognitive, and psychological sequelae and require extensive interdisciplinary support. This study illustrates a typical case of cerebellar mutism in a child after resection of medulloblastoma, followed by a review of associated symptoms, clinical course, and modulating factors. Additionally, recommendations for providing educational support to children with cerebellar mutism are explored.


Journal of Clinical Oncology | 2017

Death Within 1 Month of Diagnosis in Childhood Cancer: An Analysis of Risk Factors and Scope of the Problem.

Adam L. Green; Elissa Furutani; Karina Braga Ribeiro; Carlos Rodriguez Galindo

Purpose Despite advances in childhood cancer care, some patients die soon after diagnosis. This population is not well described and may be under-reported. Better understanding of risk factors for early death and scope of the problem could lead to prevention of these occurrences and thus better survival rates in childhood cancer. Methods We retrieved data from SEER 13 registries on 36,337 patients age 0 to 19 years diagnosed with cancer between 1992 and 2011. Early death was defined as death within 1 month of diagnosis. Socioeconomic status data for each individuals county of residence were derived from Census 2000. Crude and adjusted odds ratios and corresponding 95% CIs were estimated for the association between early death and demographic, clinical, and socioeconomic factors. Results Percentage of early death in the period was 1.5% (n = 555). Children with acute myeloid leukemia, infant acute lymphoblastic leukemia, hepatoblastoma, and malignant brain tumors had the highest risk of early death. On multivariable analysis, an age younger than 1 year was a strong predictor of early death in all disease groups examined. Black race and Hispanic ethnicity were both risk factors for early death in multiple disease groups. Residence in counties with lower than median average income was associated with a higher risk of early death in hematologic malignancies. Percentages of early death decreased significantly over time, especially in hematologic malignancies. Conclusion Risk factors for early death in childhood cancer include an age younger than 1 year, specific diagnoses, minority race and ethnicity, and disadvantaged socioeconomic status. The population-based disease-specific percentages of early death were uniformly higher than those reported in cooperative clinical trials, suggesting that early death is under-reported in the medical literature. Initiatives to identify those at risk and develop preventive interventions should be prioritized.


Pediatrics | 2014

Delayed Diagnosis and False Relapse Due to Paternal Testosterone Use in Adrenocortical Carcinoma

Adam L. Green; Abhinash Srivatsa; Carlos Rodriguez-Galindo

The prognosis of pediatric adrenocortical carcinoma often depends on prompt diagnosis to begin treatment before metastatic progression. We discuss a girl who presented at 8 months of age with virilization, which was thought to be due to exposure to a topical testosterone preparation being used by her father. Her testosterone level did not decrease promptly after her father discontinued the medication, however, and when she followed up with signs of Cushing syndrome 5 months later, metastatic adrenocortical carcinoma was diagnosed. The patient was successfully treated with surgery and multiagent chemotherapy. Nine months after the end of treatment, her testosterone level was again found to be elevated. Testosterone precursors were now absent, however, and there were no imaging signs of recurrence. Further history showed that her father had restarted topical testosterone, and this time, exogenous exposure was correctly diagnosed. As use of topical testosterone becomes more prevalent, exogenous exposure must be considered in the differential diagnosis of childhood virilization. Any persistent testosterone elevation after exposure ceases or signs of hypercortisolism, however, are inconsistent with this diagnosis. We believe that the risk-benefit ratio favors abdominal ultrasound to rule out malignancy in all children presenting with virilization.


Pediatric Blood & Cancer | 2016

A Prospective Cohort Quality Improvement Study to Reduce the Time to Antibiotics for New Fever in Neutropenic Pediatric Oncology Inpatients.

Adam L. Green; Joanna Yi; Natalie Bezler; Yana Pikman; Venée N. Tubman; Esther A. Obeng; Teresa O'Neil; Robert Mersereau; Lisa Morrissey; Amy L. Billett

Fever and neutropenia (F&N) is a pediatric oncology emergency due to the risk of disseminated infection. Quality improvement (QI) efforts to improve time to antibiotics for F&N in the emergency department have been documented, but the issue has not been studied in the established inpatient setting.


Neuro-oncology | 2018

DIPG-55. TARGETING SENESCENT CELLS WITH ABT-263 ENHANCES CELL DEATH INDUCED BY BMI1 INHIBITION AND IONIZING RADIATION IN DIPG

Ilango Balakrishnan; Krishna Madhavan; Angela Pierce; Nathan A Dahl; Rakeb Lemma; Susan Fosmire; Dong Wang; Eric Prince; Irina Alimova; Rintaro Hashizume; Esther Huellman; Cynthia Hawkins; Angel M. Carcaboso; Nalin Gupta; Michelle Monje; Keneth Jones; Adam L. Green; Nicholas K. Foreman; Rajeev Vibhakar; Sujatha Venkataraman


Oncotarget | 2017

Early death in pediatric cancer: remaining questions and next steps

Elissa Furutani; Carlos Rodriguez-Galindo; Adam L. Green


Neuro-oncology | 2017

HGG-16. A COMPARISON OF PRIMARY AND RECURRENT PEDIATRIC HIGH-GRADE GLIOMAS VIA RNA SEQUENCING AND DRUG SCREENING

Patrick Flannery; John DeSisto; Rakeb Lemma; Andrew M. Donson; Nicholas K. Foreman; Rajeev Vibhakar; Kenneth L. Jones; Adam L. Green


Neuro-oncology | 2017

PDTM-01. PEDIATRIC RADIATION-INDUCED GLIOBLASTOMA: TRANSCRIPTOMIC AND DRUG SCREENING ANALYSIS OF PRIMARY PATIENT SAMPLES

John DeSisto; Andrew M. Donson; Patrick Flannery; Rakeb Lemma; Bridget Sanford; Nicholas K. Foreman; Rajeev Vibhakar; Kenneth L. Jones; Adam L. Green

Collaboration


Dive into the Adam L. Green's collaboration.

Top Co-Authors

Avatar

Carlos Rodriguez-Galindo

St. Jude Children's Research Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Rajeev Vibhakar

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Rakeb Lemma

University of Colorado Denver

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Andrew M. Donson

University of Colorado Denver

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

John DeSisto

University of Colorado Denver

View shared research outputs
Top Co-Authors

Avatar

Kenneth L. Jones

University of Colorado Denver

View shared research outputs
Top Co-Authors

Avatar

Patrick Flannery

University of Colorado Denver

View shared research outputs
Researchain Logo
Decentralizing Knowledge